Companies: 10,795·Total market cap: $144.5T
PolyPid Ltd.

PolyPid Ltd.

PYPDNASDAQHealthcare● Active
$4.62
+$0.12(+2.67%)
Market Cap$47081958
P/E Ratio
52W High$5.21
52W Low$2.77
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

PolyPid Ltd. (PYPD) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001611842 · PYPD · NASDAQ · as of Jun 9, 2026

Filing snapshot

232
Total Filings
6-K
Latest Form
2026-06-01
Most Recent
2020
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001611842 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-02-25
Fiscal Year End
Feb 25, 2026
Accession No.
0001213900-26-020370
Primary Document
ea0276727-20f_polypid.htm
Source: data.sec.gov · CIK 0001611842 · Accession 0001213900-26-020370

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-01
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-01
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-12
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-04
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-06
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-06
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-31
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-26
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-26
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-23
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-23
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-23
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
Showing 1–15 of 232 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001611842  |  Exchange: NASDAQ · Healthcare

PolyPid Ltd. (NASDAQ: PYPD) has submitted 232 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001611842, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is PolyPid Ltd.'s most comprehensive regulatory disclosure. The most recent PolyPid Ltd. 10-K was filed on 2026-02-25 for fiscal year ending 2026. Historical PYPD 10-K annual reports are available from 2014 through 2026.

Investors researching PolyPid Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

PYPD SEC Filings · 8 questions

PolyPid Ltd. (PYPD) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 232 filings and access original documents at no cost. PolyPid Ltd.'s CIK is 0001611842.

PYPD SEC filingsPolyPid Ltd. SEC documentsfind PYPD 10-K